ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 32 filers reported holding ASLAN PHARMACEUTICALS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $29,795 | -40.4% | 82,763 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $50,000 | +11.1% | 82,763 | -9.5% | 0.00% | 0.0% |
| Q2 2022 | $45,000 | -45.1% | 91,470 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $82,000 | -19.6% | 91,470 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $102,000 | -69.5% | 91,470 | -51.3% | 0.00% | -77.8% |
| Q3 2021 | $334,000 | -22.7% | 187,862 | +43.5% | 0.01% | -35.7% |
| Q2 2021 | $432,000 | -1.6% | 130,919 | -0.0% | 0.01% | -12.5% |
| Q1 2021 | $439,000 | +13.4% | 130,920 | -38.1% | 0.02% | +14.3% |
| Q4 2020 | $387,000 | – | 211,464 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,270,758 | $2,262,000 | 0.72% |
| MANGROVE PARTNERS IM, LLC | 2,514,576 | $4,476,000 | 0.40% |
| TANG CAPITAL MANAGEMENT LLC | 975,305 | $1,736,000 | 0.36% |
| DAFNA Capital Management LLC | 732,500 | $1,304,000 | 0.35% |
| KNOTT DAVID M | 478,186 | $851,000 | 0.31% |
| Vivo Capital, LLC | 2,840,909 | $5,057,000 | 0.23% |
| SABBY MANAGEMENT, LLC | 688,400 | $1,225,000 | 0.17% |
| MYDA Advisors LLC | 236,165 | $420,000 | 0.12% |
| Affinity Asset Advisors, LLC | 250,000 | $445,000 | 0.11% |
| RTW INVESTMENTS, LP | 3,250,000 | $5,785,000 | 0.09% |